Long term immune response of universal hepatitis B vaccination in infancy: A community-based study in Taiwan

Pediatric Infectious Disease Journal

Volumn 18, Issue 5, 1999, Pages 427-432

  Shih, Hsiang Hung ^a   Chang, Mei Hwei ^a   Hsu, Hong Yuan ^a   Lee, Ping Ing ^a   Ni, Yen Hsuan ^a   Chen, Ding Shinn ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Booster; Hepatitis B vaccine; Immunologic memory; Long term immunity

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ANAMNESIS; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS B; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOLOGICAL MEMORY; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SEROCONVERSION; TAIWAN; VACCINATION;

CHILD; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; INFANT; INFANT, NEWBORN; MALE; TAIWAN;

EID: 0033061114     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199905000-00006     Document Type: Article

References (28)

1. Committee on Infectious Diseases. American Academy of Pediatrics. Universal hepatitis B immunization. Pediatrics 1992;89:795-800.
2. Chang MH, Chen CJ, Lai MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med. 1997;336:1855-9.
3. Kane M. Global programme for control of hepatitis B infection. Vaccine 1995;13(Suppl 1):S47-9.
4. Chen HL, Chang MH, Ni YH, et al. Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan. J Am Med Assoc 1996;276:906-8.
5. Hsu HY, Chang MH, Chen DS, Lee CY, Sung JL. Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before a mass hepatitis B vaccination program in Taiwan. J Med Virol 1986;18:301-7.
6. Tsen YJ, Chang MH, Hsu HY, Lee CY, Sung JL, Chen DS. Seroprevalence of hepatitis B infection in children in Taipei, 1989: five years after a mass hepatitis B vaccination program. J Med Virol 1991;34:96-9.
7. Wainwright RB, McMahon BJ, Bulkow LR, et al. Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population: preliminary results of an 8-year study. In: Hollinger FB, Lemon SM, Margolis HS, eds. Viral hepatitis and liver disease. Baltimore: Williams & Wilkins, 1991: 762-6.
8. Coursaget P, Leboulleux D, Soumare M, et al. Twelve-year follow-up study of hepatitis B immunization of Senegalese infants. J Hepatol 1994;21:250-4.
9. Margolis HS. Prevention of acute and chronic liver disease through immunization: hepatitis B and beyond. J Infect Dis 1993;168:9-14.
10. Coursaget P, Yvonnet B, Gilks WR, et al. Scheduling of revaccination against hepatitis B virus. Lancet 1991;337: 1180-3.
11. Gesemann M, Scheiermann N. Quantification of hepatitis B vaccine-induced antibodies as a predictor of anti-HBs persistence. Vaccine 1995;13:443-7.
12. Hadler SC, Francis DP, Maynard JE, et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med 1986;315:209-14.
13. Whittle HC, Inskip H, Hall AJ, et al. Vaccination against hepatitis B and protection against chronic viral carriage in the Gambia. Lancet 1991;337:747-50.
14. Jlig W, Schmidt M, Deinhardt F. Persistence of specific antibodies after hepatitis B vaccination. J Hepatol 1988;6: 201-7.
15. Hsu NHM, Chen DS, Chuang CH, et al. Studies on the efficacy of a mass immunization program against hepatitis B in Taiwan: a three-year follow-up. In: Coursaget P, Tong MJ, eds. Progress in hepatitis B immunization. Paris: John Libby Eurotext, 1990:509-17.
16. Hwang LY, Lee CY, Beasley RP. Five-year follow-up of HBV vaccination with plasma-derived vaccine in neonates: evaluation of immunogenicity and efficacy against perinatal transmission. In: Hollinger FB, Lemon SM, Morgalis HS, eds. Viral hepatitis and liver disease. Baltimore: Williams & Wilkins, 1991:759-61.
17. McIntyre PG. Hepatitis B vaccination follow-up. Lancet 1995; 345:1575.
18. West DJ, Calandra GB. Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination. Vaccine 1996;14:1019-27.
19. van Haffum J, Maikoe T, Poel J, DeGast GC. Persistence of immune memory in responders to hepatitis B vaccination who subsequently lost serum anti-HBs [Abstract]. Neth J Med 1991;39:74.
20. Chen DS, Hsu NHM, Sung JL, et al. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA 1987;257:2597-603.
21. Resti M, Azzari C, Rossi ME, et al. Five-year follow-up of vaccination against hepatitis B virus in newborns vaccinated with a reduced number of doses. Vaccine 1991;9:15-8.
22. Gonzalez ML, Gonzalez JB, Salva F, Lardinois R. A 7-year follow-up of newborns vaccinated against hepatitis B. Vaccine 1993;11:1033-6.
23. Ding L, Zhang M, Wang Y, et al. A 9-year follow-up study of the immunogenicity and long-term efficacy of plasma-derived hepatitis B vaccine in high-risk Chinese neonates. Clin Infect Dis 1993;17:475-9.
24. Stevens CE, Toy PT, Taylor PE, Lee T, Yip HY. Prospects for control of hepatitis B virus infection: implications of childhood vaccination and long-term protection. Pediatrics 1992; 90:170-3.
25. Hsu HY, Chang MH, Ho HN, et al. Association of HLA-DR14-DR52 with low responsiveness to hepatitis B vaccine in Chinese residents in Taiwan. Vaccine. 1993;11:1437-9.
26. Moyes CD, Milne A, Waldon J. Very low dose hepatitis B vaccination in the newborn: anamnestic response to booster at four years. J Med Virol 1990;30:216-8.
27. West DJ, Watson B, Lichtman J, Hesley TM, Hedberg K. Persistence of immunologic memory for twelve years in children given hepatitis B vaccine in infancy. Pediatr Infect Dis J 1994;13:745-7.
28. Lai CL, Wong BCY, Yeoh EK, Lim WL, Chang WK, Lin HJ. Five-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine vs. plasma-derived vaccine in children: immunogenicity and anamnestic responses. Hepatology 1993;18:763-7.